PUMA BIOTECHNOLOGY, INC. (PBYI) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2011: -$1.82M2012: -$44.01M2016: -$141.69M2017: -$172.47M2018: -$24.11M2019: $22.38M2020: $773.0K2021: $20.65M2022: -$15.83M2023: $27.01M2024: $38.92M2025: $41.80M$41.80M
2011Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$41.80M+7.4%
2024$38.92M+44.1%
2023$27.01M+270.7%
2022-$15.83M-176.6%
2021$20.65M+2571.4%
2020$773.0K-96.5%
2019$22.38M+192.8%
2018-$24.11M+86.0%
2017-$172.47M-21.7%
2016-$141.69M
2012-$44.01M-2312.9%
2011-$1.82M